User profiles for "author:M Ramsay"
 | Mary RamsayVerified email at hpa.org.uk Cited by 50570 |
Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit
Objective: To revise the “Clinical Practice Guidelines for the Sustained Use of Sedatives and
Analgesics in the Critically Ill Adult” published in Critical Care Medicine in 2002. Methods …
Analgesics in the Critically Ill Adult” published in Critical Care Medicine in 2002. Methods …
Global epidemiology of meningococcal disease
As reviewed in this paper, meningococcal disease epidemiology varies substantially by
geographic area and time. The disease can occur as sporadic cases, outbreaks, and large …
geographic area and time. The disease can occur as sporadic cases, outbreaks, and large …
Factors underlying parental decisions about combination childhood vaccinations including MMR: a systematic review
Suboptimal childhood vaccination uptake results in disease outbreaks, and in developed
countries is largely attributable to parental choice. To inform evidence-based interventions …
countries is largely attributable to parental choice. To inform evidence-based interventions …
[HTML][HTML] Effectiveness of Covid-19 vaccines against the B. 1.617. 2 (Delta) variant
Abstract Background The B. 1.617. 2 (delta) variant of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19) …
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19) …
[HTML][HTML] Effectiveness of Covid-19 vaccines against the B. 1.617. 2 (Delta) variant
Background The B. 1.617. 2 (delta) variant of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19) …
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19) …
[HTML][HTML] SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort …
Background Increased understanding of whether individuals who have recovered from
COVID-19 are protected from future SARS-CoV-2 infection is an urgent requirement. We …
COVID-19 are protected from future SARS-CoV-2 infection is an urgent requirement. We …
[HTML][HTML] Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV …
Background Few data exist on the comparative safety and immunogenicity of different
COVID-19 vaccines given as a third (booster) dose. To generate data to optimise selection …
COVID-19 vaccines given as a third (booster) dose. To generate data to optimise selection …
Controlled sedation with alphaxalone-alphadolone
MAE Ramsay, TM Savege, BRJ Simpson, R Goodwin - Br med J, 1974 - bmj.com
Alphaxalone-alphadolone (Althesin), diluted and administered as a controlled infusion, was
used as a sedative for 30 patients in an intensive therapy unit. This technique allowed rapid …
used as a sedative for 30 patients in an intensive therapy unit. This technique allowed rapid …
[HTML][HTML] Duration of protection against mild and severe disease by Covid-19 vaccines
Background Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2), the virus that causes coronavirus disease 2019 (Covid-19), have been used since …
2), the virus that causes coronavirus disease 2019 (Covid-19), have been used since …
[HTML][HTML] Covid-19 vaccine effectiveness against the Omicron (B. 1.1. 529) variant
Background A rapid increase in coronavirus disease 2019 (Covid-19) cases due to the
omicron (B. 1.1. 529) variant of severe acute respiratory syndrome coronavirus 2 in highly …
omicron (B. 1.1. 529) variant of severe acute respiratory syndrome coronavirus 2 in highly …